speb/financial-data huggingface dataset:
PROTEAN.NS income_statement (annual, 2023-03-31) — Write Off: 1200000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — +Operating Expense: 2821200000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — +Total Revenue: 8759200000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1198600000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1892900000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1643700000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 468100000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -680200000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Amortization: 45200000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 306400000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 40437801.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Basic EPS: 24.06
PROTEAN.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 171400000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 536400000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -317300000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Capital Expenditure Reported: -82300000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 207900000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 404500000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 459300000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 599000000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -404500000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 0.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 459300000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -465800000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 78300000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Change In Payable: -119700000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -193300000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -700500000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 287900000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Common Stock: 404500000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -404500000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 9261800000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 12400000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 0.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 5295100000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Current Assets: 4367900000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 86400000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 86400000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Current Deferred Assets: 2500000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 2237800000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 85600000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Deferred Tax: 4500000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Depreciation: 274800000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 274800000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 274800000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 229600000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 40639007.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Diluted EPS: 23.94
PROTEAN.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 972900000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 3200000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — EBIT: 1295300000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — EBITDA: 1570100000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — End Cash Position: 459300000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 250000000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -474500000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 258100000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -3200000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 295600000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 339800000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 2573100000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 2295000000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Gross Profit: 3464100000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Held To Maturity Securities: 5114200000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 23300000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Interest Expense: 16700000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 16700000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Interest Income: 483000000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 483000000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -16700000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 504100000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 9261800000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: 187000000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 5670600000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 12400000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 121500000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 121500000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 233200000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 1266300000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Minority Interest: -1900000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Minority Interests: 0.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 12400000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Net Income: 972900000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 972900000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 972900000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 972900000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 972900000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 1278600000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 972900000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: -152300000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Net Interest Income: 466300000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -3000000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 466300000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Net PPE: 651300000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -82700000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 8922000000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Assets: 0.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 0.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 214800000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 233200000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 90300000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 1593400000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Normalized Income: 990629211.64
PROTEAN.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 575400000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Operating Income: 642900000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Operating Revenue: 8759200000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 40446732.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 1200000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 12500000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 144000000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 339800000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -446200000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 5100000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 189500000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 1830900000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Other Payable: 287200000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Other Properties: 492300000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 349400000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 139700000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Payables: 1651000000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 85600000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 306000000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Pretax Income: 1278600000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 389100000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: -152300000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -550000000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -82700000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 5295100000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 274800000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 10600000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 10600000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 1048300000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 4258700000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 547000000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 157200000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 452800000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Share Issued: 40446732.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Special Income Charges: -23300000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 130600000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 9261800000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 8922000000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -5570788.36
PROTEAN.NS income_statement (annual, 2024-03-31) — Tax Provision: 305700000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.24
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 168600000.00
PROTEAN.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -352300000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Total Assets: 11852400000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 9261800000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Total Debt: 207900000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 9259900000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Total Expenses: 8116300000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 2592500000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 7484500000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 354700000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 165200000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -23300000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -23300000.00
PROTEAN.NS balance_sheet (annual, 2024-03-31) — Working Capital: 2130100000.00
PROTEAN.NS income_statement (annual, 2024-03-31) — Write Off: 0.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 1312400000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 1980800000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 6119600000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 195000000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 405400000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 566800000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 2168300000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 405400000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 9488800000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 4691800000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 72100000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 72100000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 2729600000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 54000000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 519000000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 653800000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 9488800000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 6119600000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 122900000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 122900000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 217100000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: -1900000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 653800000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 8969800000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 194200000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 40540347.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 542700000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 657800000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 9083400000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 519000000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 2600000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 653800000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1601500000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Payables: 1312400000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 40540347.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 9488800000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 8969800000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 12556500000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 9488800000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 195000000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 9486900000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 3069600000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 7864700000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 340000000.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 0.00
PROTEAN.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 1962200000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 297300000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 2023100000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 40512367.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 5.66
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 1626100000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 58100000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 58100000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 40873440.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 5.61
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 229300000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — EBIT: 287800000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — EBITDA: 345900000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 397000000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 2600000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 2600000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Minority Interests: 0.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Net Income: 229300000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 229300000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 229300000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 229300000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 229300000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 229300000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -2600000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -2600000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 345900000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 229300000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Operating Income: 99700000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 2023100000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 188100000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 239200000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 285200000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 1626100000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 58100000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 55900000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.20
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 1923400000.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
PROTEAN.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
PROTEAN.NS income_statement (annual, 2025-03-31) — +Operating Expense: 1423000000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 442500000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — +Total Revenue: 8407000000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2221500000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 1033000000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1033000000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 1440700000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1440700000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1748000000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1748000000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 562900000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 562900000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -345700000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -345700000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Amortization: 85100000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 559400000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 559400000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 40499343.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 40476190.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Basic EPS: 22.83
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 5.04
PROTEAN.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 459300000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 536600000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 536600000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -475600000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Capital Expenditure Reported: -215300000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 685300000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 685300000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 405500000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 405500000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 378500000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 378500000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2014200000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2014200000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -404600000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 378500000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 378500000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 495500000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 289700000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Change In Payable: -165600000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 549300000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 1168900000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -80800000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Common Stock: 405500000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 405500000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -404600000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 9987800000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 9987800000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 57100000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1200000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1200000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 6458100000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1681100000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Current Assets: 4710300000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 4710300000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 83300000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 83300000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 83300000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 83300000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Current Deferred Assets: 0.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Assets: 0.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 2259300000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2259300000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 99000000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 99000000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Deferred Tax: 0.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Depreciation: 278200000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 278200000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 278200000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 81000000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 278200000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 81000000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 40821192.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 40476190.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Diluted EPS: 22.65
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 924600000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 204000000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 0.00
PROTEAN.NS income_statement (annual, 2025-03-31) — EBIT: 1207700000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — EBIT: 263300000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — EBITDA: 1485900000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — EBITDA: 344300000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — End Cash Position: 378500000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 250000000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 250000000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -422400000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 1451500000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -44400000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 349800000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 484500000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 484500000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 1786400000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1786400000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 2898300000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2898300000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Gross Profit: 1948900000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 540400000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Held To Maturity Securities: 4721400000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 4721400000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: 114000000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Interest Expense: 23400000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 10900000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 23400000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 10900000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Interest Income: 510400000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 510400000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -23400000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 505200000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 9987800000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 9987800000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -1585500000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 5530800000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 5530800000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 57100000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 602000000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 602000000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 602000000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 602000000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 216500000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 216500000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 1385700000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1385700000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 0.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 0.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Minority Interests: 0.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 57100000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Net Income: 924600000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Net Income: 204000000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 924600000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 204000000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 924600000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 204000000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 924600000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 204000000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 924600000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 204000000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 1184300000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 924600000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 204000000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -129700000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Net Interest Income: -23400000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -10900000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -1615100000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -23400000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -10900000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Net PPE: 1150300000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 1150300000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -130600000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 9503300000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 9503300000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Assets: 0.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 0.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 0.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 0.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 137200000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 137200000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 216500000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 216500000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 132500000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 132500000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1485900000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 344300000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Normalized Income: 924600000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 204000000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 1927100000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Operating Income: 525900000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Operating Income: 97900000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Operating Revenue: 8407000000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 2221500000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 40548239.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 40548239.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 13700000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 13700000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 52600000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 52600000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 268000000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 268000000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 484500000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 484500000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -588800000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 1000000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1000000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 681800000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 165400000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 1144800000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 361500000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Other Payable: 306800000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 306800000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Other Properties: 974800000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 974800000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 4500000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 4500000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 1635700000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1635700000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Other Special Charges: -6700000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Payables: 1575900000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Payables: 1575900000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 99000000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 99000000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 139400000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 139400000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Pretax Income: 1184300000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 252400000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: -96600000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -129700000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -4550900000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -130600000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 6458100000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1681100000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 278200000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 81000000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 18700000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 18700000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 983700000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 983700000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 4764900000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 4764900000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 2935800000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 211100000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 560900000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Share Issued: 40548239.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 40548239.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 162700000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 9987800000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 9987800000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 9503300000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 9503300000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Tax Provision: 259700000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 48400000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.22
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.19
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 114100000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 114100000.00
PROTEAN.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -251200000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Total Assets: 13065600000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 13065600000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 9987800000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 9987800000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Total Debt: 685300000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 685300000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 9987800000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 9987800000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Total Expenses: 7881100000.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 2123600000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 3077800000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3077800000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 8355300000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 8355300000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 818500000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 818500000.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 236100000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 236100000.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
PROTEAN.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
PROTEAN.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
PROTEAN.NS balance_sheet (annual, 2025-03-31) — Working Capital: 2451000000.00
PROTEAN.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 2451000000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 328700000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 2108400000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 40561224.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 5.88
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1726000000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 110400000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 110400000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 40769231.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 5.85
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 238500000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — EBIT: 338900000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — EBITDA: 449300000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 382400000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 15200000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 15200000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Net Income: 238500000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 238500000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 238500000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 238500000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 238500000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 238500000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -15200000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -15200000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 449300000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 238500000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Operating Income: 53700000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 2108400000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 285200000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 218300000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 323700000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1726000000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 110400000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 85200000.00
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
PROTEAN.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 2054700000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 385300000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 2288700000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 40540541.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 5.55
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1698200000.00